Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells. (Record no. 24836944)

MARC details
000 -LEADER
fixed length control field 01445 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517030435.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201604s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1756-9966
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1186/s13046-015-0157-2
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name van Haaften, Caroline
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20160413
245 00 - TITLE STATEMENT
Title Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of experimental & clinical cancer research : CR
Date of publication, distribution, etc. Apr 2015
300 ## - PHYSICAL DESCRIPTION
Extent 38 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cisplatin
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Synergism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lactones
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ovarian Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Paclitaxel
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sesquiterpenes
General subdivision pharmacology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Boot, Arnoud
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Corver, Willem E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name van Eendenburg, Jaap D H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Trimbos, Baptist J M Z
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name van Wezel, Tom
773 0# - HOST ITEM ENTRY
Title Journal of experimental & clinical cancer research : CR
Related parts vol. 34
-- p. 38
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1186/s13046-015-0157-2">https://doi.org/10.1186/s13046-015-0157-2</a>
Public note Available from publisher's website

No items available.